Trends in chlamydia positivity over time among women in melbourne Australia, 2003 to 2007

K. M. O'Rourke, K. M. O'Rourke, Christopher K. Fairley, Christopher K. Fairley, Anil Samaranayake, Anil Samaranayake, Peter Collignon, Jane S. Hocking

Research output: Contribution to journalArticleResearchpeer-review

23 Citations (Scopus)

Abstract

Background: Our aim was to determine whether the proportion of women testing positive for chlamydia had changed over time after adjusting for demographic, clinical, and sexual risk factors. Methods: Computerized records for all heterosexual women attending a large urban sexual health clinic for the first time between 2003 and 2007 and were tested for chlamydia, were included. Chlamydia positivity and 95% confidence intervals were calculated and logistic regression was used to assess any possible change in chlamydia positivity over time after adjusting for demographic, clinical, and sexual risk factors. National chlamydia surveillance and testing data and data of the use of antibiotics effective against chlamydia were analyzed and trends over time evaluated using linear regression. Results: There were 10,498 chlamydia tests conducted among female clients presenting to the clinic for their first time over the 5 years (2003-2007). Chlamydia positivity was 5.9% (95% CI: 5.5%-6.4%). Chlamydia positivity increased each year from 4.2% in 2003 to 6.7% in 2007 (P <0.01). After adjusting for other factors, chlamydia positivity increased on average 12% per year (OR = 1.12; 95% CI: 1.05-1.20). The average daily defined dose of antibiotics effective against chlamydia prescribed in Australia declined significantly between 1992 and 2002 (from 20.2 to 12.6 per 1000 population; P <0.01) at a time when chlamydia positivity across Australia was increasing (from 9.4% to 10.7%; P = 0.06). Conclusions: These data suggest that the true prevalence of chlamydia in Australia is rising. One biologically plausible explanation that requires further study is that fewer antibiotics are being prescribed that would inadvertently also treat chlamydia infection.
Original languageEnglish
Pages (from-to)763-767
Number of pages5
JournalSexually Transmitted Diseases
Volume36
Issue number12
DOIs
Publication statusPublished - 1 Dec 2009

Cite this

O&apos;Rourke, K. M. ; O&apos;Rourke, K. M. ; Fairley, Christopher K. ; Fairley, Christopher K. ; Samaranayake, Anil ; Samaranayake, Anil ; Collignon, Peter ; Hocking, Jane S. / Trends in chlamydia positivity over time among women in melbourne Australia, 2003 to 2007. In: Sexually Transmitted Diseases. 2009 ; Vol. 36, No. 12. pp. 763-767.
@article{a307d653088d4370b7c46e42db5d53f1,
title = "Trends in chlamydia positivity over time among women in melbourne Australia, 2003 to 2007",
abstract = "Background: Our aim was to determine whether the proportion of women testing positive for chlamydia had changed over time after adjusting for demographic, clinical, and sexual risk factors. Methods: Computerized records for all heterosexual women attending a large urban sexual health clinic for the first time between 2003 and 2007 and were tested for chlamydia, were included. Chlamydia positivity and 95{\%} confidence intervals were calculated and logistic regression was used to assess any possible change in chlamydia positivity over time after adjusting for demographic, clinical, and sexual risk factors. National chlamydia surveillance and testing data and data of the use of antibiotics effective against chlamydia were analyzed and trends over time evaluated using linear regression. Results: There were 10,498 chlamydia tests conducted among female clients presenting to the clinic for their first time over the 5 years (2003-2007). Chlamydia positivity was 5.9{\%} (95{\%} CI: 5.5{\%}-6.4{\%}). Chlamydia positivity increased each year from 4.2{\%} in 2003 to 6.7{\%} in 2007 (P <0.01). After adjusting for other factors, chlamydia positivity increased on average 12{\%} per year (OR = 1.12; 95{\%} CI: 1.05-1.20). The average daily defined dose of antibiotics effective against chlamydia prescribed in Australia declined significantly between 1992 and 2002 (from 20.2 to 12.6 per 1000 population; P <0.01) at a time when chlamydia positivity across Australia was increasing (from 9.4{\%} to 10.7{\%}; P = 0.06). Conclusions: These data suggest that the true prevalence of chlamydia in Australia is rising. One biologically plausible explanation that requires further study is that fewer antibiotics are being prescribed that would inadvertently also treat chlamydia infection.",
author = "O&apos;Rourke, {K. M.} and O&apos;Rourke, {K. M.} and Fairley, {Christopher K.} and Fairley, {Christopher K.} and Anil Samaranayake and Anil Samaranayake and Peter Collignon and Hocking, {Jane S.}",
year = "2009",
month = "12",
day = "1",
doi = "10.1097/OLQ.0b013e3181b12765",
language = "English",
volume = "36",
pages = "763--767",
journal = "Sexually Transmitted Diseases",
issn = "0148-5717",
publisher = "Lippincott Williams & Wilkins",
number = "12",

}

O&apos;Rourke, KM, O&apos;Rourke, KM, Fairley, CK, Fairley, CK, Samaranayake, A, Samaranayake, A, Collignon, P & Hocking, JS 2009, 'Trends in chlamydia positivity over time among women in melbourne Australia, 2003 to 2007', Sexually Transmitted Diseases, vol. 36, no. 12, pp. 763-767. https://doi.org/10.1097/OLQ.0b013e3181b12765

Trends in chlamydia positivity over time among women in melbourne Australia, 2003 to 2007. / O&apos;Rourke, K. M.; O&apos;Rourke, K. M.; Fairley, Christopher K.; Fairley, Christopher K.; Samaranayake, Anil; Samaranayake, Anil; Collignon, Peter; Hocking, Jane S.

In: Sexually Transmitted Diseases, Vol. 36, No. 12, 01.12.2009, p. 763-767.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Trends in chlamydia positivity over time among women in melbourne Australia, 2003 to 2007

AU - O&apos;Rourke, K. M.

AU - O&apos;Rourke, K. M.

AU - Fairley, Christopher K.

AU - Fairley, Christopher K.

AU - Samaranayake, Anil

AU - Samaranayake, Anil

AU - Collignon, Peter

AU - Hocking, Jane S.

PY - 2009/12/1

Y1 - 2009/12/1

N2 - Background: Our aim was to determine whether the proportion of women testing positive for chlamydia had changed over time after adjusting for demographic, clinical, and sexual risk factors. Methods: Computerized records for all heterosexual women attending a large urban sexual health clinic for the first time between 2003 and 2007 and were tested for chlamydia, were included. Chlamydia positivity and 95% confidence intervals were calculated and logistic regression was used to assess any possible change in chlamydia positivity over time after adjusting for demographic, clinical, and sexual risk factors. National chlamydia surveillance and testing data and data of the use of antibiotics effective against chlamydia were analyzed and trends over time evaluated using linear regression. Results: There were 10,498 chlamydia tests conducted among female clients presenting to the clinic for their first time over the 5 years (2003-2007). Chlamydia positivity was 5.9% (95% CI: 5.5%-6.4%). Chlamydia positivity increased each year from 4.2% in 2003 to 6.7% in 2007 (P <0.01). After adjusting for other factors, chlamydia positivity increased on average 12% per year (OR = 1.12; 95% CI: 1.05-1.20). The average daily defined dose of antibiotics effective against chlamydia prescribed in Australia declined significantly between 1992 and 2002 (from 20.2 to 12.6 per 1000 population; P <0.01) at a time when chlamydia positivity across Australia was increasing (from 9.4% to 10.7%; P = 0.06). Conclusions: These data suggest that the true prevalence of chlamydia in Australia is rising. One biologically plausible explanation that requires further study is that fewer antibiotics are being prescribed that would inadvertently also treat chlamydia infection.

AB - Background: Our aim was to determine whether the proportion of women testing positive for chlamydia had changed over time after adjusting for demographic, clinical, and sexual risk factors. Methods: Computerized records for all heterosexual women attending a large urban sexual health clinic for the first time between 2003 and 2007 and were tested for chlamydia, were included. Chlamydia positivity and 95% confidence intervals were calculated and logistic regression was used to assess any possible change in chlamydia positivity over time after adjusting for demographic, clinical, and sexual risk factors. National chlamydia surveillance and testing data and data of the use of antibiotics effective against chlamydia were analyzed and trends over time evaluated using linear regression. Results: There were 10,498 chlamydia tests conducted among female clients presenting to the clinic for their first time over the 5 years (2003-2007). Chlamydia positivity was 5.9% (95% CI: 5.5%-6.4%). Chlamydia positivity increased each year from 4.2% in 2003 to 6.7% in 2007 (P <0.01). After adjusting for other factors, chlamydia positivity increased on average 12% per year (OR = 1.12; 95% CI: 1.05-1.20). The average daily defined dose of antibiotics effective against chlamydia prescribed in Australia declined significantly between 1992 and 2002 (from 20.2 to 12.6 per 1000 population; P <0.01) at a time when chlamydia positivity across Australia was increasing (from 9.4% to 10.7%; P = 0.06). Conclusions: These data suggest that the true prevalence of chlamydia in Australia is rising. One biologically plausible explanation that requires further study is that fewer antibiotics are being prescribed that would inadvertently also treat chlamydia infection.

UR - http://www.scopus.com/inward/record.url?scp=73949139563&partnerID=8YFLogxK

U2 - 10.1097/OLQ.0b013e3181b12765

DO - 10.1097/OLQ.0b013e3181b12765

M3 - Article

C2 - 19801964

AN - SCOPUS:73949139563

VL - 36

SP - 763

EP - 767

JO - Sexually Transmitted Diseases

JF - Sexually Transmitted Diseases

SN - 0148-5717

IS - 12

ER -